Literature DB >> 6651417

Osteogenesis imperfecta and Paget's disease of bone. Biochemical and morphologic studies.

J R Shapiro, T Triche, D W Rowe, A Munabi, H S Cattell, S Schlesinger.   

Abstract

Osteogenesis imperfecta (OI) and Paget's disease of bone occurred in a patient whose brother has Paget's disease. Several other relatives have the dominant variety of OI. The familial occurrence of the two diseases is presumably due to chance and, to our knowledge, has not been previously reported. Examination of iliac crest bone biopsy specimens showed mild changes of both diseases in the proband. Electron microscopy of the bone collagen demonstrated type I collagen fibers, which are reduced in number, decreased in diameter, and stellate rather than smooth in outline. Three populations of collagen fibers were observed in the bone. The synthesis of type I collagen by dermal fibroblasts was diminished in the proband and affected relatives, but it was normal in the unaffected relatives. Since collagen fibers with a stellate outline have not been observed in OI bone, an intriguing question is the effect to the putative Paget agent (? viral) on collagen synthesis in OI.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651417

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  Characterization of human bone cells in culture.

Authors:  B Auf'mkolk; P V Hauschka; E R Schwartz
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

2.  Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

Authors:  D W Rowe; J R Shapiro; M Poirier; S Schlesinger
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Iliac bone histomorphometry in adults and children with osteogenesis imperfecta.

Authors:  L G Ste-Marie; S A Charhon; C Edouard; M C Chapuy; P J Meunier
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.